• LAST PRICE
    11.0500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    13.0000/ 223
  • Ask / Lots
    13.1500/ 1
  • Open / Previous Close
    --- / 11.0500
  • Day Range
    ---
  • 52 Week Range
    Low 4.9200
    High 12.9700
  • Volume
    10,713
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 11.23
TimeVolumeREPL
09:32 ET1034411.23
09:33 ET10011.26
09:35 ET40011.24
09:37 ET79211.23
09:44 ET50211.28
09:46 ET17911.3545
09:48 ET138211.28
09:51 ET59811.29
09:55 ET305111.135
09:57 ET66011.21
10:00 ET58711.159489
10:02 ET10011.2
10:04 ET15011.165
10:06 ET10011.17
10:08 ET650011.12
10:09 ET65911.065
10:11 ET116811.14
10:13 ET49711.15
10:15 ET114911.19
10:18 ET61411.23
10:20 ET117411.255
10:22 ET43511.27
10:24 ET424911.22
10:26 ET33911.14
10:27 ET20011.145
10:31 ET90011.11
10:33 ET133311.1
10:36 ET10011.115
10:42 ET80011.085
10:44 ET80011.14
10:47 ET20011.15
10:49 ET152311.14
10:56 ET20011.11
10:58 ET2769511.04
11:00 ET70011
11:02 ET20011.02
11:03 ET290811.04
11:05 ET101511.07
11:07 ET10011.07
11:09 ET20011.03
11:12 ET20011.06
11:14 ET50011.0108
11:16 ET48611.05
11:18 ET86511.05
11:20 ET37711.04
11:21 ET30011.03
11:23 ET139711.03
11:25 ET67511.025
11:27 ET101711.02
11:30 ET110011.06
11:32 ET253411.035
11:34 ET80011.02
11:36 ET335811.09
11:38 ET80011.06
11:39 ET41411.0403
11:41 ET87611.05
11:43 ET10011.05
11:45 ET10011.06
11:48 ET20011.05
11:50 ET10011.05
11:54 ET199411.09
11:57 ET223011.09
11:59 ET123211.095
12:01 ET40011.1
12:06 ET20011.085
12:08 ET10011.06
12:10 ET10011.06
12:12 ET10011.0609
12:14 ET30011.07
12:15 ET30011.07
12:17 ET131011.08
12:19 ET10011.08
12:21 ET70211.09
12:24 ET101011.07
12:26 ET10011.08
12:30 ET136611.1
12:32 ET199211.085
12:33 ET272711.08
12:35 ET10011.06
12:37 ET68011.08
12:39 ET59311.085
12:44 ET100011.1
12:46 ET100011.105
12:48 ET130011.1
12:50 ET70011.07
12:57 ET250011.09
01:00 ET1227711.11
01:02 ET20011.11
01:04 ET92611.09
01:06 ET20011.1
01:08 ET50011.09
01:09 ET197511.12
01:11 ET20011.08
01:15 ET100011.05
01:18 ET248611.07
01:20 ET40411.085
01:24 ET10011.085
01:26 ET431411.09
01:27 ET38911.09
01:29 ET107511.07
01:31 ET164911.1
01:33 ET66111.09
01:36 ET506311.09
01:38 ET50011.09
01:40 ET45311.08
01:42 ET70011.08
01:45 ET60011.1
01:47 ET129711.07
01:54 ET2722011.01
01:56 ET327011.01
02:00 ET20011.02
02:03 ET185111.01
02:05 ET50311.01
02:07 ET81011.01
02:09 ET110011
02:12 ET209711
02:14 ET164011
02:16 ET20011
02:18 ET60011
02:20 ET82911
02:23 ET220911.02
02:25 ET20011.02
02:27 ET10011.02
02:32 ET120011.02
02:34 ET230211.06
02:36 ET13011.05
02:38 ET157311.09
02:39 ET179811.07
02:41 ET170011.06
02:43 ET23711.06
02:45 ET10011.06
02:48 ET29911.065
02:50 ET193211.04
02:52 ET75011.05
02:56 ET115411.05
02:57 ET61111.05
02:59 ET126411.02
03:01 ET60011.02
03:03 ET59311.01
03:08 ET241411
03:10 ET34011.02
03:14 ET40011.02
03:15 ET345611
03:17 ET30011.01
03:19 ET107811.02
03:21 ET280411.05
03:24 ET129511.04
03:26 ET237711.05
03:28 ET210011.07
03:30 ET117611.06
03:32 ET70011.05
03:33 ET237411.06
03:35 ET198311.05
03:37 ET123411.07
03:39 ET209311.05
03:42 ET225711.05
03:44 ET154511.07
03:46 ET251811.06
03:48 ET170011.06
03:50 ET252611.05
03:51 ET860111.07
03:53 ET120011.07
03:55 ET302711.075
03:57 ET1344311.06
04:00 ET19254811.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesREPL
Replimune Group Inc
755.0M
-3.6x
---
United StatesAVXL
Anavex Life Sciences Corp
764.9M
-18.0x
---
United StatesAUTL
Autolus Therapeutics PLC
755.7M
-2.4x
---
United StatesERAS
Erasca Inc
734.5M
-3.1x
---
United StatesTYRA
Tyra Biosciences Inc
777.3M
-9.6x
---
United StatesKURA
Kura Oncology Inc
782.3M
-4.3x
---
As of 2024-11-22

Company Information

Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. It is also developing additional product candidates, RP2 and RP3, to enhance anti-tumor immune responses and are intended to address additional tumor types, including traditionally less immune responsive tumor types. RP2 additionally expresses an anti-CTLA-4 antibody-like molecule, as well as GALV-GP R- and GM-CSF.

Contact Information

Headquarters
500 Unicorn Park DrWOBURN, MA, United States 01801-3377
Phone
781-222-9600
Fax
302-655-5049

Executives

Executive Chairman of the Board
Philip Astley-Sparke
Chief Executive Officer, Director
Sushil Patel
Chief Financial Officer
Emily Hill
Chief Commercial Officer
Christopher Sarchi
Chief Medical Officer
Konstantinos Xynos

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$755.0M
Revenue (TTM)
$0.00
Shares Outstanding
68.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.20
EPS
$-3.05
Book Value
$6.10
P/E Ratio
-3.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.